Skip to main content

Maria Teresa Mateu Peláez

Institutions of which they are part

Predoctoral researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Maria Teresa Mateu Peláez

Institutions of which they are part

Predoctoral researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Related news

Two international studies led by Vall d'Hebron recommend early administration of specific drugs to prevent migraine to achieve a better response to therapy.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

The study, conducted in more than 770 people, concludes that atogepant reduces the frequency of migraine attacks and the need to take medication.

Related professionals

Joaquin Lopez Soriano

Joaquin Lopez Soriano

P Management and Admin. Project manager
Clinical Trials Management Unit
Clinical Research Development Directorate
Read more
Júlia Comulada Ferrer

Júlia Comulada Ferrer

Research technician
Clinical Neuroimmunology
Read more
José Antonio Arranz  Amo

José Antonio Arranz Amo

Postdoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
CINTHYA FLORES LAMAS

CINTHYA FLORES LAMAS

Medium Grade Technician
Clinical Trials Management Unit
Clinical Research Development Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.